Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences (NQ: PACB )

2.235 -0.105 (-4.49%)
Streaming Delayed Price Updated: 11:42 AM EST, Dec 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences

< Previous 1 2 3 4 5 6 7 8 9 Next >
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight
Cathie Wood is investing in PacBio, a biotech company with potential for genomics revolution. ARK Invest is confident in its long-term growth. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Deciphering Disruption: Inside Cathie Wood's Latest Plays
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The rock star money manager is starting to roll with the rallying market. 
Via The Motley Fool
What 5 Analyst Ratings Have To Say About Pacific Biosciences
Via Benzinga
Analyst Scoreboard: 5 Ratings For Pacific Biosciences
Via Benzinga
Peering Into Pacific Biosciences's Recent Short Interest
Via Benzinga
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
Via ACCESSWIRE
How Is The Market Feeling About Pacific Biosciences?
Via Benzinga
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
Via Benzinga
A Biotech Breakout Will Be Led By Small Caps
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday
Via Benzinga
Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024
PACB stock results show that Pacific Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
Via MarketBeat
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Via Benzinga
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
Jefferies Financial Group sees these three companies as prime candidates among stocks for double-digit returns. 
Via InvestorPlace
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Via Benzinga
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. 
Via Benzinga
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.